Jennifer A. Wellman
Geschäftsführer bei AKOUOS
Aktive Positionen von Jennifer A. Wellman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AKOUOS | Geschäftsführer | 01.10.2020 | - |
General Counsel | 01.03.2018 | 01.10.2020 | |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | 12.07.2021 | - |
Independent Dir/Board Member | 12.07.2021 | - |
Karriereverlauf von Jennifer A. Wellman
Ehemalige bekannte Positionen von Jennifer A. Wellman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Raymond G. Perelman Center for Cellular & Molecular | General Counsel | 01.01.2005 | 01.01.2013 |
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01.01.2000 | 01.01.2005 |
SPARK THERAPEUTICS, INC. | Gründer | 13.03.2013 | - |
General Counsel | 13.03.2013 | - |
Ausbildung von Jennifer A. Wellman
Queen's University | Undergraduate Degree |
University of New Haven | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Kanada | 2 |
Operativ
General Counsel | 3 |
Founder | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Akouos, Inc.
Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Health Technology |
Raymond G. Perelman Center for Cellular & Molecular |
- Börse
- Insiders
- Jennifer A. Wellman
- Erfahrung